Middle East and Africa Hereditary Transthyretin Amyloidosis Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	113 Pages	Data Bridge Market Research	August, 2023	DAABD18185794

Best Price Guarantee
Price	from $3,500
Length	113 Pages
Publisher	Data Bridge Market Research
Published Date	August, 2023
SKU	DAABD18185794

Middle East and Africa Hereditary Transthyretin Amyloidosis Market

The Middle East and Africa hereditary transthyretin amyloidosis market is expected to reach USD 10, 65,985.45 thousand by 2030 from USD 51,673.84 thousand in 2022, growing at a CAGR of 3.1% in the forecast period of 2023 to 2030.

Market Segmentation
Middle East and Africa Hereditary Transthyretin Amyloidosis Market, By Diagnosis and Treatment (Diagnosis and Treatment), Gene Variation (V122L, T60A, V30M, and Others), Gender (Male and Female), Indication (Cardiomyopathy (ATTR-CM), Polyneuropathy (ATTR-PN), and Mixed Indications), End-User (Hospitals and Clinics, Diagnostic Laboratories, Radiology Centers, Academic and Research Institutes, Ambulatory Surgical Centers, and Homecare) Distribution Channel (Direct Tender, Third Party Distributors, Hospital Pharmacy, Retail Pharmacy, and Others), Country (South Africa, U.A.E., Egypt, Saudi Arabia, Kuwait, and Rest of the Middle East and Africa) – Industry Trends and Forecast to 2030

Overview of Middle East and Africa Hereditary Transthyretin Amyloidosis Market Dynamics

Driver
• Rising prevalence of hereditary transthyretin amyloidosis

Restraint

• Stringent regulatory approvals for hereditary transthyretin amyloidosis

Opportunity

• Government initiatives for hereditary transthyretin amyloidosis
Market Players

Some of the key market players operating in the Middle East and Africa hereditary transthyretin amyloidosis market are:

• Pfizer Inc.
• Koninklijke Philips N.V.
• Siemens Healthcare GmbH
• CANON MEDICAL SYSTEMS CORPORATION
• MinFound Medical Systems Co.
• Alnylam Pharmaceuticals, Inc.
• NIHON KOHDEN CORPORATION.
• GE HealthCare.(A Subsidary of General Electric)
• FONAR Corp.
• Neusoft Corporation
• Shimadzu Corporation
• SCHILLER
• Novo Nordisk A/S
• AstraZeneca

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The Middle East And Africa Hereditary Transthyretin Amyloidosis Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Diagnosis And Treatment Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Market End-user Coverage Grid; 2.11 Vendor Share Analysis; 2.12 Secondary Sources; 2.13 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel's Model; 4.2 Porter's 5 Forces; 4.3 Pipeline Analysis
5 Regulatory Scenario
6 Market Overview: 6.1 Drivers; 6.1.1 Rising Prevalence Of Hereditary Transthyretin Amyloidosis; 6.1.2 Increasing Research And Clinical Trials For Hereditary Transthyretin Amyloidosis; 6.1.3 Advancement In Gene Therapy 41; 6.2 Restraints; 6.2.1 Stringent Regulatory Approvals For Hereditary Transthyretin Amyloidosis Treatment; 6.2.2 High Cost Associated With Hereditary Transthyretin Amyloidosis Treatment; 6.3 Opportunities; 6.3.1 Government Initiatives For Hereditary Transthyretin Amyloidosis Treatment; 6.3.2 Strategic Initiatives By The Market Players; 6.4 Challenges; 6.4.1 Complexity In Diagnosing Hereditary Transthyretin Amyloidosis; 6.4.2 Limited Patient Pool For Hereditary Transthyretin Amyloidosis
7 Middle East And Africa Hereditary Transthyretin Amyloidosis Market : By Countries
8 Middle East And Africa Hereditary Transthyretin Amyloidosis Market, Company Landscape: 8.1 Company Share Analysis: Middle East And Africa
9 Swot Analysis
10 Company Profile: 10.1 Pfizer Inc.; 10.1.1 Company Snapshot; 10.1.2 Revenue Analysis; 10.1.3 Product Portfolio; 10.1.4 Recent Development; 10.2 Ge Healthcare.( A Subsidary Of General Electric); 10.2.1 Company Snapshot; 10.2.2 Revenue Analysis; 10.2.3 Product Portfolio; 10.2.4 Recent Development; 10.3 Siemens Healthcare Gmbh; 10.3.1 Company Snapshot; 10.3.2 Revenue Analysis; 10.3.3 Product Portfolio; 10.3.4 Recent Development 88; 10.4 Koninklijke Philips N.V.; 10.4.1 Company Snapshot; 10.4.2 Revenue Analysis; 10.4.3 Product Portfolio; 10.4.4 Recent Development; 10.5 Canon Medical Systems Corporation; 10.5.1 Company Snapshot; 10.5.2 Revenue Analysis; 10.5.3 Product Portfolio; 10.5.4 Recent Development; 10.6 Alnylam Pharmaceuticals, Inc.; 10.6.1 Company Snapshot; 10.6.2 Revenue Analysis; 10.6.3 Product Portfolio; 10.6.4 Recent Development; 10.7 Astrazeneca; 10.7.1 Company Snapshot; 10.7.2 Revenue Analysis; 10.7.3 Product Portfolio; 10.7.4 Recent Development; 10.8 Fonar Corp.; 10.8.1 Company Snapshot; 10.8.2 Revenue Analysis; 10.8.3 Product Portfolio; 10.8.4 Recent Development; 10.9 Minfound Medical Systems Co.,; 10.9.1 Company Snapshot; 10.9.2 Product Portfolio; 10.9.3 Recent Development; 10.10 Neusoft Corporation; 10.10.1 Company Snapshot; 10.10.2 Revenue Analysis; 10.10.3 Product Portfolio; 10.10.4 Recent Development; 10.11 Nihon Kohden Corporation.; 10.11.1 Company Snapshot; 10.11.2 Recent Financials; 10.11.3 Product Portfolio; 10.11.4 Recent Development 103; 10.12 Novo Nordisk A/S; 10.12.1 Company Snapshot; 10.12.2 Revenue Analysis; 10.12.3 Product Portfolio; 10.12.4 Recent Development; 10.13 Schiller; 10.13.1 Company Snapshot; 10.13.2 Product Portfolio; 10.13.3 Recent Development; 10.14 Shimadzu Corporation; 10.14.1 Company Snapshot; 10.14.2 Revenue Analysis; 10.14.3 Product Portfolio; 10.14.4 Recent Development
11 Questionnaire
12 Related Reports
List Of Tables: Table 1 Middle East And Africa Hereditary Transthyretin Amyloidosis Market, Pipeline Analysis; Table 2 Middle East And Africa Hereditary Transthyretin Amyloidosis Market, By Country, 2021-2030 (Usd Thousand); Table 3 Middle East And Africa Hereditary Transthyretin Amyloidosis Market, By Diagnosis And Treatment, 2021-2030 (Usd Thousand); Table 4 Middle East And Africa Diagnosis In Hereditary Transthyretin Amyloidosis Market, By Tests, 2021-2030 (Usd Thousand); Table 5 Middle East And Africa Imaging Test In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 6 Middle East And Africa Nuclear Imaging In Hereditary Transthyretin Amyloidosis Market, By Imaging Test, 2021-2030 (Usd Thousand); Table 7 Middle East And Africa Biopsy In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 8 Middle East And Africa Treatment In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 9 Middle East And Africa Medications In Hereditary Transthyretin Amyloidosis Market, By Approval, 2021-2030 (Usd Thousand); Table 10 Middle East And Africa Approved Medications In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 11 Middle East And Africa Pipeline Medications In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 12 Middle East And Africa Medications In Hereditary Transthyretin Amyloidosis Market, By Mode Of Action, 2021-2030 (Usd Thousand); Table 13 Middle East And Africa Gene Silencer In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 14 Middle East And Africa Medications In Hereditary Transthyretin Amyloidosis Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 15 Middle East And Africa Parenteral In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 16 Middle East And Africa Hereditary Transthyretin Amyloidosis Market, By Gene Variation, 2021-2030 (Usd Thousand); Table 17 Middle East And Africa Hereditary Transthyretin Amyloidosis Market, By Gender, 2021-2030 (Usd Thousand); Table 18 Middle East And Africa Hereditary Transthyretin Amyloidosis Market, By Indication, 2021-2030 (Usd Thousand); Table 19 Middle East And Africa Polyneuropathy (Attr-pn) In Hereditary Transthyretin Amyloidosis Market, By Stages, 2021-2030 (Usd Thousand); Table 20 Middle East And Africa Hereditary Transthyretin Amyloidosis Market, By End User, 2021-2030 (Usd Thousand); Table 21 Middle East And Africa Hereditary Transthyretin Amyloidosis Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 22 South Africa Hereditary Transthyretin Amyloidosis Market, By Diagnosis And Treatment, 2021-2030 (Usd Thousand); Table 23 South Africa Diagnosis In Hereditary Transthyretin Amyloidosis Market, By Tests, 2021-2030 (Usd Thousand); Table 24 South Africa Imaging Test In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 25 South Africa Nuclear Imaging In Hereditary Transthyretin Amyloidosis Market, By Imaging Test, 2021-2030 (Usd Thousand); Table 26 South Africa Biopsy In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 27 South Africa Treatment In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 28 South Africa Medications In Hereditary Transthyretin Amyloidosis Market, By Approval, 2021-2030 (Usd Thousand); Table 29 South Africa Approved Medications In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 30 South Africa Pipeline Medications In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 31 South Africa Medications In Hereditary Transthyretin Amyloidosis Market, By Mode Of Action, 2021-2030 (Usd Thousand); Table 32 South Africa Gene Silencer In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 33 South Africa Medications In Hereditary Transthyretin Amyloidosis Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 34 South Africa Parenteral In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 35 South Africa Hereditary Transthyretin Amyloidosis Market, By Gene Variation, 2021-2030 (Usd Thousand); Table 36 South Africa Hereditary Transthyretin Amyloidosis Market, By Gender, 2021-2030 (Usd Thousand); Table 37 South Africa Hereditary Transthyretin Amyloidosis Market, By Indication, 2021-2030 (Usd Thousand); Table 38 South Africa Polyneuropathy (Attr-pn) In Hereditary Transthyretin Amyloidosis Market, By Stages, 2021-2030 (Usd Thousand); Table 39 South Africa Hereditary Transthyretin Amyloidosis Market, By End User, 2021-2030 (Usd Thousand); Table 40 South Africa Hereditary Transthyretin Amyloidosis Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 41 Saudi Arabia Hereditary Transthyretin Amyloidosis Market, By Diagnosis And Treatment, 2021-2030 (Usd Thousand); Table 42 Saudi Arabia Diagnosis In Hereditary Transthyretin Amyloidosis Market, By Tests, 2021-2030 (Usd Thousand); Table 43 Saudi Arabia Imaging Test In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 44 Saudi Arabia Nuclear Imaging In Hereditary Transthyretin Amyloidosis Market, By Imaging Test, 2021-2030 (Usd Thousand); Table 45 Saudi Arabia Biopsy In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 46 Saudi Arabia Treatment In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 47 Saudi Arabia Medications In Hereditary Transthyretin Amyloidosis Market, By Approval, 2021-2030 (Usd Thousand); Table 48 Saudi Arabia Approved Medications In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 49 Saudi Arabia Pipeline Medications In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 50 Saudi Arabia Medications In Hereditary Transthyretin Amyloidosis Market, By Mode Of Action, 2021-2030 (Usd Thousand); Table 51 Saudi Arabia Gene Silencer In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 52 Saudi Arabia Medications In Hereditary Transthyretin Amyloidosis Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 53 Saudi Arabia Parenteral In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 54 Saudi Arabia Hereditary Transthyretin Amyloidosis Market, By Gene Variation, 2021-2030 (Usd Thousand); Table 55 Saudi Arabia Hereditary Transthyretin Amyloidosis Market, By Gender, 2021-2030 (Usd Thousand); Table 56 Saudi Arabia Hereditary Transthyretin Amyloidosis Market, By Indication, 2021-2030 (Usd Thousand); Table 57 Saudi Arabia Polyneuropathy (Attr-pn) In Hereditary Transthyretin Amyloidosis Market, By Stages, 2021-2030 (Usd Thousand); Table 58 Saudi Arabia Hereditary Transthyretin Amyloidosis Market, By End User, 2021-2030 (Usd Thousand); Table 59 Saudi Arabia Hereditary Transthyretin Amyloidosis Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 60 U.A.E Hereditary Transthyretin Amyloidosis Market, By Diagnosis And Treatment, 2021-2030 (Usd Thousand); Table 61 U.A.E Diagnosis In Hereditary Transthyretin Amyloidosis Market, By Tests, 2021-2030 (Usd Thousand); Table 62 U.A.E Imaging Test In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 63 U.A.E Nuclear Imaging In Hereditary Transthyretin Amyloidosis Market, By Imaging Test, 2021-2030 (Usd Thousand); Table 64 U.A.E Biopsy In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 65 U.A.E Treatment In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 66 U.A.E Medications In Hereditary Transthyretin Amyloidosis Market, By Approval, 2021-2030 (Usd Thousand); Table 67 U.A.E Approved Medications In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 68 U.A.E Pipeline Medications In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 69 U.A.E Medications In Hereditary Transthyretin Amyloidosis Market, By Mode Of Action, 2021-2030 (Usd Thousand); Table 70 U.A.E Gene Silencer In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 71 U.A.E Medications In Hereditary Transthyretin Amyloidosis Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 72 U.A.E Parenteral In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 73 U.A.E Hereditary Transthyretin Amyloidosis Market, By Gene Variation, 2021-2030 (Usd Thousand); Table 74 U.A.E Hereditary Transthyretin Amyloidosis Market, By Gender, 2021-2030 (Usd Thousand); Table 75 U.A.E Hereditary Transthyretin Amyloidosis Market, By Indication, 2021-2030 (Usd Thousand); Table 76 U.A.E Polyneuropathy (Attr-pn) In Hereditary Transthyretin Amyloidosis Market, By Stages, 2021-2030 (Usd Thousand); Table 77 U.A.E Hereditary Transthyretin Amyloidosis Market, By End User, 2021-2030 (Usd Thousand); Table 78 U.A.E Hereditary Transthyretin Amyloidosis Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 79 Egypt Hereditary Transthyretin Amyloidosis Market, By Diagnosis And Treatment, 2021-2030 (Usd Thousand); Table 80 Egypt Diagnosis In Hereditary Transthyretin Amyloidosis Market, By Tests, 2021-2030 (Usd Thousand); Table 81 Egypt Imaging Test In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 82 Egypt Nuclear Imaging In Hereditary Transthyretin Amyloidosis Market, By Imaging Test, 2021-2030 (Usd Thousand); Table 83 Egypt Biopsy In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 84 Egypt Treatment In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 85 Egypt Medications In Hereditary Transthyretin Amyloidosis Market, By Approval, 2021-2030 (Usd Thousand); Table 86 Egypt Approved Medications In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 87 Egypt Pipeline Medications In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 88 Egypt Medications In Hereditary Transthyretin Amyloidosis Market, By Mode Of Action, 2021-2030 (Usd Thousand); Table 89 Egypt Gene Silencer In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 90 Egypt Medications In Hereditary Transthyretin Amyloidosis Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 91 Egypt Parenteral In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 92 Egypt Hereditary Transthyretin Amyloidosis Market, By Gene Variation, 2021-2030 (Usd Thousand); Table 93 Egypt Hereditary Transthyretin Amyloidosis Market, By Gender, 2021-2030 (Usd Thousand); Table 94 Egypt Hereditary Transthyretin Amyloidosis Market, By Indication, 2021-2030 (Usd Thousand); Table 95 Egypt Polyneuropathy (Attr-pn) In Hereditary Transthyretin Amyloidosis Market, By Stages, 2021-2030 (Usd Thousand); Table 96 Egypt Hereditary Transthyretin Amyloidosis Market, By End User, 2021-2030 (Usd Thousand); Table 97 Egypt Hereditary Transthyretin Amyloidosis Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 98 Israel Hereditary Transthyretin Amyloidosis Market, By Diagnosis And Treatment, 2021-2030 (Usd Thousand); Table 99 Israel Diagnosis In Hereditary Transthyretin Amyloidosis Market, By Tests, 2021-2030 (Usd Thousand); Table 100 Israel Imaging Test In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 101 Israel Nuclear Imaging In Hereditary Transthyretin Amyloidosis Market, By Imaging Test, 2021-2030 (Usd Thousand); Table 102 Israel Biopsy In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 103 Israel Treatment In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 104 Israel Medications In Hereditary Transthyretin Amyloidosis Market, By Approval, 2021-2030 (Usd Thousand); Table 105 Israel Approved Medications In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 106 Israel Pipeline Medications In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 107 Israel Medications In Hereditary Transthyretin Amyloidosis Market, By Mode Of Action, 2021-2030 (Usd Thousand); Table 108 Israel Gene Silencer In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 109 Israel Medications In Hereditary Transthyretin Amyloidosis Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 110 Israel Parenteral In Hereditary Transthyretin Amyloidosis Market, By Type, 2021-2030 (Usd Thousand); Table 111 Israel Hereditary Transthyretin Amyloidosis Market, By Gene Variation, 2021-2030 (Usd Thousand); Table 112 Israel Hereditary Transthyretin Amyloidosis Market, By Gender, 2021-2030 (Usd Thousand); Table 113 Israel Hereditary Transthyretin Amyloidosis Market, By Indication, 2021-2030 (Usd Thousand); Table 114 Israel Polyneuropathy (Attr-pn) In Hereditary Transthyretin Amyloidosis Market, By Stages, 2021-2030 (Usd Thousand); Table 115 Israel Hereditary Transthyretin Amyloidosis Market, By End User, 2021-2030 (Usd Thousand); Table 116 Israel Hereditary Transthyretin Amyloidosis Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 117 Rest Of Middle East And Africa Hereditary Transthyretin Amyloidosis Market, By Diagnosis And Treatment, 2021-2030 (Usd Thousand)
List Of Figures: Figure 1 Middle East And Africa Hereditary Transthyretin Amyloidosis Market: Segmentation; Figure 2 Middle East And Africa Hereditary Transthyretin Amyloidosis Market: Data Triangulation; Figure 3 Middle East And Africa Hereditary Transthyretin Amyloidosis Market: Droc Analysis; Figure 4 Middle East And Africa Hereditary Transthyretin Amyloidosis Market: Regional Vs Country Market Analysis; Figure 5 Middle East And Africa Hereditary Transthyretin Amyloidosis Market: Company Research Analysis; Figure 6 Middle East And Africa Hereditary Transthyretin Amyloidosis Market: Interview Demographics; Figure 7 Middle East And Africa Hereditary Transthyretin Amyloidosis Market: Dbmr Market Position Grid; Figure 8 Middle East And Africa Hereditary Transthyretin Amyloidosis Market: Market End-user Coverage Grid; Figure 9 Middle East And Africa Hereditary Transthyretin Amyloidosis Market: Vendor Share Analysis; Figure 10 Middle East And Africa Hereditary Transthyretin Amyloidosis Market: Segmentation; Figure 11 Rising Prevalence Of Hereditary Transthyretin Amyloidosis Is Expected To Drive The Middle East And Africa Hereditary Transthyretin Amyloidosis Market Growth In The Forecast Period; Figure 12 The Diagnosis Segment Is Expected To Account For The Largest Share Of The Middle East And Africa Hereditary Transthyretin Amyloidosis Market In 2023 And 2030; Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Middle East And Africa Hereditary Transthyretin Amyloidosis Market; Figure 14 Middle East And Africa Hereditary Transthyretin Amyloidosis Market: Snapshot (2022); Figure 15 Middle East And Africa Hereditary Transthyretin Amyloidosis Market: Company Share 2022 (%)